Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mesoblast

11.17
+0.06000.54%
Volume:182.07K
Turnover:2.04M
Market Cap:1.43B
PE:-12.11
High:11.32
Open:11.06
Low:11.03
Close:11.11
Loading ...

Mesoblast Limited Announces Quotation of New Securities on ASX

TIPRANKS
·
Yesterday

JPMorgan Chase Ceases Substantial Holding in Mesoblast

TIPRANKS
·
08 Jul

JPMorgan Acquires Substantial Stake in Mesoblast Limited

TIPRANKS
·
07 Jul

Buy Rating for Mesoblast: FDA Alignment and Promising Revascor Data Drive Optimism

TIPRANKS
·
04 Jul

Mesoblast Aligns with FDA on Biologics License Application Requirements for Ischemic Heart Failure Drug Candidate, Shares Rise 6%

MT Newswires Live
·
01 Jul

Mesoblast Ltd - to File for Accelerated Approval by Year-End

THOMSON REUTERS
·
01 Jul

Why is the Mesoblast share price up 11% in June?

MotleyFool
·
17 Jun

Mesoblast Seeks to Extend Ryoncil Label to Adults With Graft Versus Host Disease; Shares Rise 3%

MT Newswires Live
·
12 Jun

Mesoblast Advances FDA Approvals for Revascor® and Ryoncil®

TIPRANKS
·
12 Jun

Vanguard Group Acquires Substantial Stake in Mesoblast Limited

TIPRANKS
·
06 Jun

JPMorgan Becomes Substantial Holder in Mesoblast Limited

TIPRANKS
·
05 Jun

Mesoblast Limited Announces Substantial Holding Update

TIPRANKS
·
03 Jun

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires Live
·
15 May

Mesoblast Receives 7-Year FDA Orphan Drug Exclusivity for Ryoncil in Pediatric Inflammatory Disease

MT Newswires Live
·
15 May

Mesoblast Receives Seven Years of Orphan-Drug Exclusive Approval for Ryoncil From US FDA

MT Newswires Live
·
15 May

Mesoblast Ltd - FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil

THOMSON REUTERS
·
15 May

JPMorgan Acquires Substantial Stake in Mesoblast Limited

TIPRANKS
·
14 May

JPMorgan Ceases Substantial Holding in Mesoblast Limited

TIPRANKS
·
09 May

State Street Corporation Ceases Substantial Holding in Mesoblast Limited

TIPRANKS
·
07 May

Mesoblast Limited Announces New Substantial Holder

TIPRANKS
·
02 May